Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Pommier

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|March 6, 1999
Mutation of a conserved serine residue in a quinolone-resistant type II topoisomerase alters the enzyme-DNA and drug interactionsD Strumberg, J L Nitiss, A Rose, et al.
Biochemical Pharmacology|October 15, 1982
Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticiniumL A Zwelling, S Michaels, D Kerrigan, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Topoisomerase II as a target of anticancer drug action in mammalian cellsK W Kohn, Y Pommier, D Kerrigan, et al.
Cancer Communications|January 1, 1990
10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cellsP M O'Connor, D Kerrigan, R Bertrand, et al.
Journal of Medicinal Chemistry|February 13, 1999
Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisonsD Strumberg, Y Pommier, K Paull, et al.
Oncology Research|January 1, 1995
Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecinR Kapoor, D L Slade, A Fujimori, et al.
The Journal of Biological Chemistry|December 5, 1993
Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistanceA Tanizawa, R Beitrand, G Kohlhagen, et al.
International Journal of Cancer|July 1, 1994
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistanceE Solary, Y H Ling, R Perez-Soler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1982
Interaction between mianserin and clonidine at alpha 2-adrenoceptorsY Pommier, M Andréjak, P Mouillé, et al.
The Journal of Clinical Investigation|December 3, 1998
Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cellsW Hiraoka, N Vazquez, W Nieves-Neira, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|March 6, 1999
Mutation of a conserved serine residue in a quinolone-resistant type II topoisomerase alters the enzyme-DNA and drug interactionsD Strumberg, J L Nitiss, A Rose, et al.
Biochemical Pharmacology|October 15, 1982
Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticiniumL A Zwelling, S Michaels, D Kerrigan, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Topoisomerase II as a target of anticancer drug action in mammalian cellsK W Kohn, Y Pommier, D Kerrigan, et al.
Cancer Communications|January 1, 1990
10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cellsP M O'Connor, D Kerrigan, R Bertrand, et al.
Journal of Medicinal Chemistry|February 13, 1999
Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisonsD Strumberg, Y Pommier, K Paull, et al.
Oncology Research|January 1, 1995
Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecinR Kapoor, D L Slade, A Fujimori, et al.
The Journal of Biological Chemistry|December 5, 1993
Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistanceA Tanizawa, R Beitrand, G Kohlhagen, et al.
International Journal of Cancer|July 1, 1994
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistanceE Solary, Y H Ling, R Perez-Soler, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1982
Interaction between mianserin and clonidine at alpha 2-adrenoceptorsY Pommier, M Andréjak, P Mouillé, et al.
The Journal of Clinical Investigation|December 3, 1998
Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cellsW Hiraoka, N Vazquez, W Nieves-Neira, et al.
Pageof 26